Insider · CIK 0001297260

Fischer Frank M

Reports to the SEC for 4 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001297260

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-19	NPCENeuroPace IncA Award	Director	AAward	+1,467 sh	$15.63	+$22.9K	599,534
2026-06-05	NPCENeuroPace Inc · Stock Option (Right to Buy)A Award	Director	AAward	+5,368 sh	—	—	5,368
2026-06-05	NPCENeuroPace IncA Award	Director	AAward	+2,890 sh	—	—	598,067
2026-03-20	NPCENeuroPace IncA Award	Director	AAward	+1,826 sh	$13.00	+$23.7K	595,177
2025-12-19	NPCENeuroPace IncA Award	Director	AAward	+1,431 sh	$16.59	+$23.7K	593,351
2025-09-19	NPCENeuroPace IncA Award	Director	AAward	+2,389 sh	$9.94	+$23.7K	591,920
2025-06-21	NPCENeuroPace IncA Award	Director	AAward	+2,281 sh	$10.41	+$23.7K	589,531
2025-06-06	NPCENeuroPace Inc · Stock Option (right to buy)A Award	Director	AAward	+8,745 sh	—	—	8,745
2025-03-21	NPCENeuroPace IncA Award	Director	AAward	+1,975 sh	$12.02	+$23.7K	587,250
2024-12-21	NPCENeuroPace IncA Award	Director	AAward	+2,059 sh	$11.53	+$23.7K	585,275
2024-09-30	NPCENeuroPace IncA Award	Director	AAward	+3,407 sh	$6.97	+$23.7K	583,216
2024-06-28	NPCENeuroPace IncA Award	Director	AAward	+3,141 sh	$7.56	+$23.7K	579,809
2024-06-07	NPCENeuroPace Inc · Stock Option (Rt to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,774
2024-03-31	NEVRO CORPA Award	Director	AAward	+1,159 sh	—	—	57,500
2024-03-29	NPCENeuroPace IncA Award	Director	AAward	+1,799 sh	$13.20	+$23.7K	576,668
2023-12-31	NEVRO CORPA Award	Director	AAward	+778 sh	—	—	56,341
2023-12-29	NPCENeuroPace IncA Award	Director	AAward	+2,303 sh	$10.31	+$23.7K	574,869
2023-09-30	NEVRO CORPA Award	Director	AAward	+871 sh	—	—	55,563
2023-09-29	NPCENeuroPace IncA Award	Director	AAward	+2,440 sh	$9.73	+$23.7K	572,566
2023-06-30	NEVRO CORPA Award	Director	AAward	+658 sh	—	—	54,692
2023-06-30	NPCENeuroPace IncA Award	Director	AAward	+4,469 sh	$4.49	+$20.1K	570,126
2023-06-07	NPCENeuroPace Inc · Stock Option (Rt to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,380
2023-05-25	NEVRO CORPA Award	Director	AAward	+6,754 sh	—	—	54,034
2023-05-22	TNONTenon Medical, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,207 sh	$1.62	+$10.1K	6,207
2023-03-31	NEVRO CORPA Award	Director	AAward	+463 sh	—	—	47,280
2022-12-30	NEVRO CORPA Award	Director	AAward	+422 sh	—	—	46,817
2022-09-30	NEVRO CORPA Award	Director	AAward	+359 sh	—	—	46,395
2022-06-30	NEVRO CORPA Award	Director	AAward	+382 sh	—	—	46,036
2022-06-13	NPCENeuroPace Inc · Stock Option (Right to Buy)A Award	Director	AAward	+18.3K sh	—	—	18,253
2022-05-26	NEVRO CORPA Award	Director	AAward	+4,155 sh	—	—	45,654
2022-03-31	NEVRO CORPA Award	Director	AAward	+231 sh	—	—	41,499
2021-12-31	NEVRO CORPA Award	Director	AAward	+206 sh	—	—	41,268
2021-09-30	NEVRO CORPA Award	Director	AAward	+143 sh	—	—	41,062
2021-06-30	NEVRO CORPA Award	Director	AAward	+101 sh	—	—	40,919
2021-05-25	NEVRO CORPA Award	Director	AAward	+1,167 sh	—	—	40,818
2021-04-26	NPCENeuroPace Inc · Series A' Preferred StockC Conversion	Director	CConversion	−21.5K sh	—	—	0
2021-04-26	NPCENeuroPace Inc · Series B' Preferred StockC Conversion	Director	CConversion	−451K sh	—	—	0
2021-04-26	NPCENeuroPace IncC Conversion	Director	CConversion	+472K sh	—	—	565,657
2021-04-21	NPCENeuroPace Inc · Stock Option (Right to Buy)A Award	Director	AAward	+21.7K sh	—	—	21,698
2021-04-21	NPCENeuroPace IncP Purchase	Director	PPurchase	+50K sh	$17.00	+$850K	93,291
2021-03-31	NEVRO CORPA Award	Director	AAward	+120 sh	—	—	39,651
2020-12-31	NEVRO CORPA Award	Director	AAward	+96 sh	—	—	39,531
2020-09-30	NEVRO CORPA Award	Director	AAward	+120 sh	—	—	39,435
2020-06-30	NEVRO CORPA Award	Director	AAward	+70 sh	—	—	39,315
2020-05-21	NEVRO CORPA Award	Director	AAward	+1,376 sh	—	—	39,245
2020-03-31	NEVRO CORPA Award	Director	AAward	+167 sh	—	—	37,869
2019-12-31	NEVRO CORPA Award	Director	AAward	+142 sh	—	—	37,702
2019-09-30	NEVRO CORPA Award	Director	AAward	+194 sh	—	—	37,560
2019-05-20	NEVRO CORPA Award	Director	AAward	+2,913 sh	—	—	37,366
2018-05-21	NEVRO CORPA Award	Director	AAward	+3,785 sh	—	—	34,453

Recent filings

Accepted (ET)
Jun 224
Fischer Frank M0001297260-26-000007
SEC(opens sec.gov)
Jun 54
Fischer Frank M0001297260-26-000005
SEC(opens sec.gov)
Mar 234
Fischer Frank M0001297260-26-000003
SEC(opens sec.gov)
Dec 234
Fischer Frank M0001297260-25-000006
SEC(opens sec.gov)
Sep 224
Fischer Frank M0001297260-25-000004
SEC(opens sec.gov)
Jun 244
Fischer Frank M0001415889-25-018088
SEC(opens sec.gov)
Jun 94
Fischer Frank M0001415889-25-016325
SEC(opens sec.gov)
Jun 114
Fischer Frank M0001415889-24-016360
SEC(opens sec.gov)
Apr 24
Fischer Frank M0001610717-24-000200
SEC(opens sec.gov)
Jan 34
Fischer Frank M0001610717-24-000004
SEC(opens sec.gov)
Oct 34
Fischer Frank M0001610717-23-000303
SEC(opens sec.gov)

Companies

Address

C/O NEUROPACE, INC. 455 N. BERNARDO AVENUE

MOUNTAIN VIEW, CA, 94043